Alphora is pleased to announce the completion of a new 3,000 sq. ft. analytical laboratory expansion. This expansion provides additional workspace for equipment and personnel to support Alphora’s growing business. The project also includes the upgrade of the data management system to EmpowerTM 3, providing a state-of-the-art platform for data and compliance management. This expansion will further support our clients’ API Technology Development programs, where comprehensive analytical understanding and control are essential for successful cGMP scale-up and to meet expanding regulatory expectations.
Alphora Research provides API technology development services to the Pharmaceutical and Biotechnology industries, including process chemistry, analytical development and validation services, and GMP scale-up. These services cover both early stage projects, where speed and quality are imperative, and later stage projects, where process economics and commercialization are vital. Alphora also provides niche commercial manufacturing and has conducted several validation campaigns in advance of market launch.
Founded in 2003 by Dr. Jan Oudenes, Alphora Research is staffed by over 90 employees and operates an FDA inspected and approved operation totaling 50,000 sq. ft., including synthetic laboratories, analytical laboratories, GMP Kilo Laboratories, GMP Pilot Plant, GMP stability studies, and supporting QC/QA. Alphora also has high potency and cytotoxic capabilities.